MAIA Biotechnology MAIA
NYSE MAIA
$1.14 +0.01 (+0.88%)
At close: Oct 23, 2026 · 4:00 PM EDT

MAIA Biotechnology (MAIA) Income from Non-Controlling Interests (2021)

Updated

MAIA Biotechnology (MAIA) reported Income from Non-Controlling Interests of -$74,331 for FY2021.

Analysis

MAIA Biotechnology (MAIA) Income from Non-Controlling Interests (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 3.00 Mn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -2.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -7.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 1.00 Mn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 10.00 Mn
10 MAIA Biotechnology 69.33 Mn -12.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 -7,130.00
Jun 30, 2021 -29,676.00
API Access

MAIA Biotechnology Income from Non-Controlling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=MAIA&period=max&api_key=YOUR_API_KEY